Medline IPO priced at $29.00
On 2025-12-16, Medline set its IPO price at $29.00 per share. The base offering covered 216034482 shares; trading was scheduled to begin on 2025-12-17.
The pricing announcement
On 2025-12-16, Medline announced a final IPO price of $29.00 per share. The base deal covered 216034482 shares and represented gross proceeds of $6,265,000,000.00 before expenses. These are launch terms, not a description of the later market price.
Why the date matters
The announcement moved Medline from the offering process into public-market trading, with the first session scheduled for 2025-12-17. In retrospect, the fixed offer price, the number of shares sold and the subsequent market price should be read separately.
Medline operates in Medical Supplies. After listing, the key questions are durable revenue, cash generation and disciplined execution.